N

Novalis LifeSciences LLC

4 employees

Novalis Lifesciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science.

Investor insights

Sectors invested in

Biotechnology14

Health Care8

Therapeutics7

Analytics4

Agriculture4

Life Science4

AgTech3

Health Diagnostics3

cell atlases2

Chemical2

crop health2

Machine Learning2

Medical Device2

high resolution2

drug development2

spatial genomics research2

spatially-resolved RNA profiling2

in situ single-cell omics2

high accuracy2

Human Cell Atlas2

Funding rounds participated in

$43M sweet spot round size

Most of their 19 investments are in rounds between $35M and $80M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Date founded

2017

Investments made

F

Flywheel.io raised $54M on June 3, 2023

Investors: Hewlett-Packard, Invenshure, LLC, Key Fund Investments, iSelect Fund, Gundersen Health System, Intuitive Ventures, Seraph Group and Novalis LifeSciences LLC

T

Telesis Bio raised $74M on May 31, 2023

Investors: BroadOak Capital Partners, Northpond Ventures and Novalis LifeSciences LLC

M

Mercy BioAnalytics, Inc. raised $41M on April 3, 2023

Investors: iSelect Fund, Sozo Ventures, Labcorp, Broadway Angels and Novalis LifeSciences LLC

L

LevitasBio raised $35M on October 24, 2022

Investors: Decheng Capital and Novalis LifeSciences LLC

U

Undisclosed raised $39M on August 23, 2022

Investors: Grand Patika, EQT Life Sciences, FundPlus, Omega Funds and Novalis LifeSciences LLC

A

Animol Discovery, Inc. raised $34M on July 28, 2022

Investors: Anterra Capital, Finistere Ventures LLC and Novalis LifeSciences LLC

E

Enko raised $70M on July 27, 2022

Investors: Germin8 Ventures, Bill & Melinda Gates Foundation, Finistere Ventures LLC and Novalis LifeSciences LLC

V

Vizgen raised $85M on June 3, 2022

Investors: Sofina, Tao Capital Partners, Northpond Ventures, ARCH Venture Partners and Novalis LifeSciences LLC

S

Sherlock Biosciences raised $80M on March 8, 2022

Investors: Albany Capital Pty Ltd, Good Ventures, Illumina Ventures, Catalio Capital Management, Northpond Ventures and Novalis LifeSciences LLC

O

Ori Biotech raised $100M on January 18, 2022

Investors: Amadeus Capital Partners, 普华资本, Octopus Ventures, Delin Ventures, Northpond Ventures and Novalis LifeSciences LLC